N Assous, L Gossec, M Dougados, A Kahan, Y Allanore. Show Affiliations »
Abstract
Entities: Chemical Disease Species
Mesh: See more » AdultAgedAntibodies, Monoclonal/administration & dosageAntibodies, Monoclonal/therapeutic useAntibodies, Monoclonal, Murine-DerivedAntirheumatic Agents/administration & dosageAntirheumatic Agents/therapeutic useArthritis, Rheumatoid/drug therapyContraindicationsDrug Therapy, CombinationEtanerceptFranceHumansImmunoglobulin GInfusions, IntravenousMethotrexate/therapeutic useMiddle AgedReceptors, Tumor Necrosis FactorRituximabTumor Necrosis Factor-alpha/antagonists & inhibitors
Substances: See more » Antibodies, MonoclonalAntibodies, Monoclonal, Murine-DerivedAntirheumatic AgentsImmunoglobulin GReceptors, Tumor Necrosis FactorTumor Necrosis Factor-alphaRituximabEtanerceptMethotrexate
Year: 2007 PMID: 17631755
Source DB: PubMed Journal: Clin Exp Rheumatol ISSN: 0392-856X Impact factor: 4.473